Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
1,323,012
-
Share change
-
+10,912
-
Total reported value
-
$88,022,480
-
Price per share
-
$66.53
-
Number of holders
-
97
-
Value change
-
+$667,429
-
Number of buys
-
25
-
Number of sells
-
40
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q4 2024
As of 31 Dec 2024,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,323,012 shares.
The largest 10 holders included
Gerber Kawasaki Wealth & Investment Management, MORGAN STANLEY, LPL Financial LLC, UBS Group AG, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, Royal Bank of Canada, GOLDMAN SACHS GROUP INC, COMMONWEALTH EQUITY SERVICES, LLC, and YHB Investment Advisors, Inc..
This page lists
97
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.